ID

20420

Descripción

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Palabras clave

Versiones (1)
  1. 22/2/17 22/2/17 -
Subido en

22 de febrero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Inglés

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 formularios  
Permanent Trial Medication
Descripción

Permanent Trial Medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0205355
1. Last intake of trial drug A, B and C (dd mon yy)
Descripción

Last Intake of Drug A, B and C

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1512806
2. Last intake of trial drug D (dd mon yy)
Descripción

Last Intake of Drug D

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1512806
3. Did the patient permanently stopped taking any of the trial medication prematurely
Descripción

Permanently stopped taking medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0850893
arm of the trial medication
Descripción

arm of the trial medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0332307
4. If yes please check which arm of the trial medication (ABC, D or all ABCD) and the reasons why for each treatment arm discontinued. (indicate one reason):
Descripción

If Yes

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0457454
A. Outcome Event (must be recorded on outcome event page)
Descripción

Outcome events

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0441471
UMLS CUI [1,2]
C1547647
UMLS CUI [1,3]
C0441471
B. Adverse Event (Specify Adverse Event below)
Descripción

Adverse Event

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
Specify Adverse Event
Descripción

Adverse Event

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2348235
UMLS CUI [1,2]
C0877248
C. Non compliant with protocol (explain below)
Descripción

Non Compliant With Protocol

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C2348563
D. Lost to follow-up (explain below)
Descripción

Lost to follow-up

Tipo de datos

integer

Alias
UMLS CUI [1]
C1522577
E. Consent withdrawn (not due to adverse event, explain below)
Descripción

Consent withdrawn

Tipo de datos

integer

Alias
UMLS CUI [1]
C1707492
F. Other (explain below)
Descripción

Other

Tipo de datos

integer

Alias
UMLS CUI [1]
C0205394
Explain
Descripción

Explain

Tipo de datos

text

Alias
UMLS CUI [1]
C1521902
Volver a la parte superior de la página

Similar models

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Permanent Trial Medication
C0013227 (UMLS CUI-1)
C0205355 (UMLS CUI-2)
Last Intake of Drug A, B and C
Item
1. Last intake of trial drug A, B and C (dd mon yy)
date
C0011008 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
Last Intake of Drug D
Item
2. Last intake of trial drug D (dd mon yy)
date
C0011008 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
Permanently stopped taking medication
Item
3. Did the patient permanently stopped taking any of the trial medication prematurely
boolean
C0850893 (UMLS CUI [1])
Item Group
arm of the trial medication
C0013227 (UMLS CUI-1)
C0332307 (UMLS CUI-2)
If Yes
Item
4. If yes please check which arm of the trial medication (ABC, D or all ABCD) and the reasons why for each treatment arm discontinued. (indicate one reason):
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Item
A. Outcome Event (must be recorded on outcome event page)
integer
C0441471 (UMLS CUI [1,1])
C1547647 (UMLS CUI [1,2])
C0441471 (UMLS CUI [1,3])
Outcome events
Code List
A. Outcome Event (must be recorded on outcome event page)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
B. Adverse Event (Specify Adverse Event below)
integer
C0877248 (UMLS CUI [1])
Outcome events
Code List
B. Adverse Event (Specify Adverse Event below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Adverse Event
Item
Specify Adverse Event
text
C2348235 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Item
C. Non compliant with protocol (explain below)
integer
C1321605 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Outcome events
Code List
C. Non compliant with protocol (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
D. Lost to follow-up (explain below)
integer
C1522577 (UMLS CUI [1])
Outcome events
Code List
D. Lost to follow-up (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
E. Consent withdrawn (not due to adverse event, explain below)
integer
C1707492 (UMLS CUI [1])
Outcome events
Code List
E. Consent withdrawn (not due to adverse event, explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
F. Other (explain below)
integer
C0205394 (UMLS CUI [1])
Outcome events
Code List
F. Other (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Explain
Item
Explain
text
C1521902 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial